Community-based Brain Health Program to Address Dementia Risk
| 适应症 | Dementia, Alzheimer Disease |
|---|---|
| 分期 | 不适用 |
| 申办方 | Posit Science Corporation |
| 状态 | 已完成 |
| 受试者人数 | 86 人 |
| 干预(药物) | Brain Health Program |
| 开始日期 | 2023年4月24日 |
| 完成日期 | 2024年10月18日 |
| 结果公布日 | 2026年7月27日 |
摘要
This is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Program in individuals with identified risk factors for the onset of dementia and to prepare for a large-scale efficacy trial in this population.
Net Promoter Score
| Brain Health Program | 65 score on a scale |
|---|
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University